Meet the Researchers Striving for a Breakthrough in Osteosarcoma Treatment
Osteosarcoma is the most common pediatric bone cancer. The disease spreads quickly, and available treatments are toxic and often ineffective. Stay up to date with the researchers who are on a mission to change that.
Subscribe for Updates
Sign up for The Frontline for leading edge research updates and patient stories.
Osteosarcoma Statistics
Meet the Researchers
Bench to Bedside: The Drug Development Process
Moving medicines from bench to bedside is critical in treating patients with all kinds of diseases and medical conditions. “Bench to bedside” research refers to a medical discovery or innovation that is translated from the research setting to the clinical setting. Another common term for this is “translational research.”
While there have been many strides in cancer-fighting drugs over the last several decades, treatment for osteosarcoma, a rare bone cancer that primarily affects children and adolescents, has remained nearly the same for the last 40 years.
Our Impact
The Osteosarcoma Institute has committed $6.8 million to osteosarcoma research since our inception. We are currently supporting a portfolio of 10 active clinical trials, correlative science, and preclinical/translational studies. Through our annual grant process, we invite the brightest minds in the field to apply for funding focused on unexplored aspects of osteosarcoma. Every applicant receives detailed feedback about their submission from our reviewers, and selected applicants are invited to submit a full proposal.
$6.8M
Our Grant Cycle
1 Submission of Letters of Intent (LOI)
2 Expert Review of LOIs
3 Applicant Feedback and Full Proposal Invitations
4 Final Expert Review
5 Award Decisions
Patient Stories
Homecoming King Leaves Lasting Impression on His Community
Scott Shockley was a star athlete throughout high school, but his real legacy was his care for others.
A Career Dedicated to Her Brother
Jasmine Smith, MD, knew she wanted to be a doctor, but she only decided on pediatric oncology as her specialty after her younger brother was diagnosed with osteosarcoma.
After Son’s Remission, a Mom Faces Caregiver Trauma
Even after receiving the good news that her son is in remission from osteosarcoma, Sarah Bright still feels lasting scars from the diagnosis.
Who We Work With
At the Osteosarcoma Institute, we care about progress — not who gets the credit. We collaborate with organizations throughout the cancer and sarcoma spaces.
“Communication between scientists is absolutely key to discovery. That is what has impressed me about the OSI. They have created a platform where scientists and clinicians are brought together to share ideas.”
Michael Brown, MD, Nobel prize winner and renowned researcher
Fund Research with the OSI
To take a bigger step in osteosarcoma advocacy, you can create your own osteosarcoma science fund with our support and infrastructure. Through a Partnering for Progress fund, we help you determine a research study or trial to support, and we handle many of the logistics, allowing you to focus on reaching out to friends and family to make a difference for osteosarcoma patients everywhere.
If you are interested in learning more about Partnering for Progress, please email giving@osinst.org and our Development Manager, Vanessa Peterson, will be in touch.
Concentrate on the Cure with Us
